Skip to main content
. Author manuscript; available in PMC: 2020 May 16.
Published in final edited form as: J Asthma. 2017 Oct 11;55(6):675–683. doi: 10.1080/02770903.2017.1362423

Table 3.

Repeated measures model comparing quality of life domain scores between patients receiving SDM toolkit intervention and matched patients in usual care (n=92)a

Variables in model Activities Score Emotions Score Symptoms Score
Mean difference (95% CI) p-value Mean difference (95% CI) p-value Mean difference (95% CI) p-value
Treatment
 Usual Care Reference Reference
 SDM Toolkit 1.0 (0.5–1.6) < 0.001 1.0 (0.5–1.6) < 0.001 0.7 (0.2–1.3) 0.009
Charlson comorbidity index −0.9 (−1.6–−0.3) 0.006 −0.8 (−1.4–−0.1) 0.030 −0.7 (−1.3–0.0) 0.049
Months from intervention 0.0 (−0.1–0.1) 0.940 0.0 (−0.1–0.0) 0.910 0.0 (−0.1–0.1) 0.940
a

Usual care and SDM toolkit participants were matched on baseline quality of life score, baseline asthma control, age, gender, insurance status, race/ethnicity, and the Charlson comorbidity index. Models were adjusted for variables that were unbalanced after matching. Quality of life domain scores from the Mini Pediatric Quality of Life Questionnaire (MPAQLQ) range from 1 to 7; higher score indicates better quality of life.